APA (7th ed.) Citation

Reiner, C. M., Schneider, M. A., Weilert, H., Welcker, K., Hoedtke, J., Mahnken, A. H., . . . Brüning, R. (2025). Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience. Cancers, 17(23), 3834. https://doi.org/10.3390/cancers17233834

Chicago Style (17th ed.) Citation

Reiner, Carolin M., Martin A. Schneider, Hauke Weilert, Klara Welcker, Jochen Hoedtke, Andreas H. Mahnken, Axel Stang, and Roland Brüning. "Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience." Cancers 17, no. 23 (2025): 3834. https://doi.org/10.3390/cancers17233834.

MLA (9th ed.) Citation

Reiner, Carolin M., et al. "Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience." Cancers, vol. 17, no. 23, 2025, p. 3834, https://doi.org/10.3390/cancers17233834.